Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inflexal V (2011/2012) Immunogenicity and Safety Study
NCT01412281Phase 3Completed
- Sponsor
- Crucell
- Start
- Oct 2011
- Primary completion
- Dec 2011
- Modality
- Nanoparticles, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of Inflexal V in influenza, sponsored by Crucell. Started Oct 2011; status: completed.
02
Drugs
Inflexal V
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01412281.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01412281.